126 related articles for article (PubMed ID: 9426431)
21. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
Aogi K; Kitahara K; Urquidi V; Tarin D; Goodison S
Clin Cancer Res; 1999 Oct; 5(10):2790-7. PubMed ID: 10537343
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
Matthews P; Jones CJ; Skinner J; Haughton M; de Micco C; Wynford-Thomas D
J Pathol; 2001 Jun; 194(2):183-93. PubMed ID: 11400147
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity in the differentiation of benign and malignant adrenal tumors.
Teng L; Tucker O; Malchoff C; Vaughan ED; Jacobson J; Fahey TJ
Surgery; 1998 Dec; 124(6):1123-7. PubMed ID: 9854593
[TBL] [Abstract][Full Text] [Related]
24. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
Saji M; Xydas S; Westra WH; Liang CK; Clark DP; Udelsman R; Umbricht CB; Sukumar S; Zeiger MA
Clin Cancer Res; 1999 Jun; 5(6):1483-9. PubMed ID: 10389936
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity in benign and malignant epithelial ovarian tumors.
Wan M; Li WZ; Duggan BD; Felix JC; Zhao Y; Dubeau L
J Natl Cancer Inst; 1997 Mar; 89(6):437-41. PubMed ID: 9091645
[TBL] [Abstract][Full Text] [Related]
26. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
27. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
[TBL] [Abstract][Full Text] [Related]
28. TRAP-silver staining, a highly sensitive assay for measuring telomerase activity in tumor tissue and cell lines.
Dalla Torre CA; Maciel RM; Pinheiro NA; Andrade JA; De Toledo SR; Villa LL; Cerutti JM
Braz J Med Biol Res; 2002 Jan; 35(1):65-8. PubMed ID: 11743616
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity in soft-tissue and bone sarcomas.
Aogi K; Woodman A; Urquidi V; Mangham DC; Tarin D; Goodison S
Clin Cancer Res; 2000 Dec; 6(12):4776-81. PubMed ID: 11156234
[TBL] [Abstract][Full Text] [Related]
30. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
31. Change of telomerase activity in rectal cancer with chemoradiation therapy.
Kim HR; Kim YJ; Kim HJ; Kim SK; Lee JH
J Korean Med Sci; 2000 Apr; 15(2):167-72. PubMed ID: 10803692
[TBL] [Abstract][Full Text] [Related]
32. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in neuroendocrine tumors.
Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization.
Heine B; Hummel M; Demel G; Stein H
J Pathol; 1998 Jun; 185(2):139-44. PubMed ID: 9713339
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activity in "suspicious" thyroid cytology.
Lerma E; Mora J
Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
[TBL] [Abstract][Full Text] [Related]
36. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activity in malignant and benign renal tumors.
Müller M; Heicappell R; Krause H; Sachsinger J; Porsche C; Miller K
Eur Urol; 1999; 35(3):249-55. PubMed ID: 10072629
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity in benign endometrium and endometrial carcinoma.
Brien TP; Kallakury BV; Lowry CV; Ambros RA; Muraca PJ; Malfetano JH; Ross JS
Cancer Res; 1997 Jul; 57(13):2760-4. PubMed ID: 9205088
[TBL] [Abstract][Full Text] [Related]
39. Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.
Guerra LN; Miler EA; Moiguer S; Karner M; Orlandi AM; Fideleff H; Burdman JA
Clin Chim Acta; 2006 Aug; 370(1-2):180-4. PubMed ID: 16600201
[TBL] [Abstract][Full Text] [Related]
40. Decrease of telomere length in thyroid adenomas without telomerase activity.
De Deken X; Vilain C; Van Sande J; Dumont JE; Miot F
J Clin Endocrinol Metab; 1998 Dec; 83(12):4368-72. PubMed ID: 9851779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
